GL1X · GenesisL1 explorer

MolNFT v1 · #88891 · protein

Influenza na in complex with antiviral compound

4D8S · Neuraminidase: “Influenza na in complex with antiviral compound”. X-ray diffraction, 2 ligands (0HX, CA), 2 pockets (best druggability 0.63). MolNFT v1 #88891 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4D8S
Type
protein
Length
388 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neuraminidase
EC
3.2.1.18
UniProt
Q07599
Ligands
0HX, CA
Pockets
2 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANeuraminidase (EC 3.2.1.18)protein3884% helix, 47% strandQ07599

Ligands and binding sites

  • 0HX · pentan-3-yl 2-acetamido-2,4-dideoxy-alpha-L-threo-hex-4-enopyranosiduronic acid · ligand · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13230.630.80480HX
2580.300.7514empty

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 4D8S · Influenza NA in complex with antiviral compound · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.